| SARS-CoV-2 | Severe Acute Respiratory Syndrome Coronavirus 2 |
| COVID-19 | Coronavirus Disease 2019 |
| WHO | World Health Organisation |
| aHR | adjusted Hazard Ratio |
| CI | Confidence Interval |
| ARDS | Acute Respiratory Distress Syndrome |
| IRR | Incidence rate ratio |
| LDL | Low Density Lipoprotein |
| ACE2 | Angiotensin Converting Enzyme 2 |
| TLR | Toll-like receptor |
| CK | Creatine Kinase |
| ALT | Alanine Transaminase |
| ULN | Upper Limit Norm |
| MβCD | Methyl-beta-cyclodextrin |
| ApoE | Apolipoprotein E |
| PLA2 | Phospholipase A2 |
| SARS-PV | retroviruses pseudotyped with SARS-CoV-2 S proteins |
| cPLA2 | cytosolic phospholipase A2 |
| Py-2 | pyrrolidyne 2 |
| TC | total cholesterol |
| HDL | High Density Lipoprotein |
| RNA | ribonucleic acidSARS-CoV-1—Severe Acute Respiratory Syndrome Coronavirus 1 |
| RAA | Renin Angiotensin Aldosterone |
| AT1R | Angiotensine 1 receptor |
| RSV | Respiratory Syncytial Virus |
| H3-Ac | histone H3 acetylation |
| HCD | High Cholesterol Diet |
| PPAR-γ | peroxisome proliferator γ receptor |
| ARBs | Angiotensin Receptor Blockers |
| Mpro | main protease |
| RdRp | RNA-dependent RNA polymerase |
| HBV | Hepatitis B Virus |
| HCV | Hepatitis C virus |
| HIV | Human Immunodeficiency Virus |
| IL-6 | interleukin 6 |
| MAS | Macrophage activating syndrome |
| CRP | C reactive protein |
| MyD88 | Myeloid differentiation primary response 88 |
| TRIF | Toll/IL-1R domain-contactiong adaptor-inducing IFN-βTRIF—Toll/IL-1R domain-contactiong adaptor-inducing IFN-β |
| IFN-β | Interferon beta |
| NF- κB | nuclear factor kappa-light-chain-enhancer of activated B cells |
| CD8+ | cluster of differentiation 8 |
| sHLH | secondary hemophagocytic lymphohistiocytosis |
| TNF-α | Tumor Necrosis Factor alpha |
| LPS | Lipopolysaccharides |
| ROS | reactive oxygen spieces |
| miRNA-221 | MicroRNA-221 |
| eNOS | endothelial nitric oxide synthase |
| KLF-2 | Krüppel-like Factor 2 |
| CSE | cystathionine γ-lyase |
| NLRP3 | NOD-, LRR- and pyrin domain-containing protein 3 |
| PXR | pregnane X receptor |
| EPCs | Endothelial Progenitor Cells |
| PE | pulmonary embolismr |
| VTE | recurrence of venous thromboembolism |
| aSHR | adjusted Hazard Ratio |
| VKA | vitamin K antagonist |
| PAI-1 | plasminogen activator inhibitor –1 |
| CT | computed tomography |
| VEGF | Vascular endothelial growth factor |
| TGFβ | transforming growth factor β |
| IPF | Idiopathic Pulmonary Fibrosis |
| OR | Odds Ratio |
| AST | aspartate aminotransferase |